These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14603351)

  • 61. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
    Sela B
    Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
    [No Abstract]   [Full Text] [Related]  

  • 62. Antiangiogenesis therapy. Current and future agents.
    Kieran MW; Billett A
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):835-51, viii. PubMed ID: 11765376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Angiogenesis inhibitors and radiotherapy].
    Riesterer O
    Praxis (Bern 1994); 2012 Aug; 101(16):1031-7. PubMed ID: 22878946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiangiogenic therapy in the management of breast cancer.
    Wu Y; Sun WL; Feng JF
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanotechnology for antiangiogenic cancer therapy.
    Kobayashi H; Lin PC
    Nanomedicine (Lond); 2006 Jun; 1(1):17-22. PubMed ID: 17716205
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antiangiogenic therapy: Markers of response, "normalization" and resistance.
    El Alaoui-Lasmaili K; Faivre B
    Crit Rev Oncol Hematol; 2018 Aug; 128():118-129. PubMed ID: 29958627
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Angiogenesis-inhibiting drugs--a future therapeutic option].
    Perbeck L
    Nord Med; 1998 Nov; 113(9):297-8, 316. PubMed ID: 9835760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiangiogenesis by chemotherapeutic agents.
    Ribatti D; Vacca A; Merchionne F; Presta M
    Mini Rev Med Chem; 2005 Mar; 5(3):313-7. PubMed ID: 15777265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Imaging in antiangiogenesis trial: a clinical trials radiology perspective.
    Kothari M; Guermazi A; White D; Suhy J; Reinhold C
    Br J Radiol; 2003; 76 Spec No 1():S92-6. PubMed ID: 15456719
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.
    Jain RK
    Cancer Cell; 2014 Nov; 26(5):605-22. PubMed ID: 25517747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Contribution of Angiogenesis to the Process of Metastasis.
    Bielenberg DR; Zetter BR
    Cancer J; 2015; 21(4):267-73. PubMed ID: 26222078
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiangiogenesis and drug delivery to tumors: bench to bedside and back.
    Duda DG
    Cancer Res; 2006 Apr; 66(8):3967-70. PubMed ID: 16618712
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer.
    Los M; Voest EE
    Semin Oncol; 2001 Feb; 28(1):93-105. PubMed ID: 11254869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Why angiogenesis inhibition? Commentary.
    Boehm-Viswanathan T
    Int J Mol Med; 1999 Oct; 4(4):413-7. PubMed ID: 10493984
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiangiogenesis therapeutic strategies in prostate cancer.
    Macpherson GR; Ng SS; Lakhani NJ; Price DK; Venitz J; Figg WD
    Cancer Metastasis Rev; 2002; 21(1):93-106. PubMed ID: 12400998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Angiogenesis and prostate cancer: important laboratory and clinical findings.
    Cox MC; Permenter M; Figg WD
    Curr Oncol Rep; 2005 May; 7(3):215-9. PubMed ID: 15847713
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug resistance associated with antiangiogenesis therapy.
    Eikesdal HP; Kalluri R
    Semin Cancer Biol; 2009 Oct; 19(5):310-7. PubMed ID: 19524042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.
    Medina MA; Muñoz-Chápuli R; Quesada AR
    J Cell Mol Med; 2007; 11(3):374-82. PubMed ID: 17635633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Significance of angiogenesis in malignant tumors].
    Smolej L; Beneová P
    Acta Medica (Hradec Kralove) Suppl; 2005; 48(2):69-72. PubMed ID: 16922159
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.
    Angiogenesis; 2004; 7 Suppl 1():1-53. PubMed ID: 15505925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.